SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001385508-22-000145
Filing Date
2022-12-21
Accepted
2022-12-21 16:55:54
Documents
4
Period of Report
2022-12-20

Document Format Files

Seq Description Document Type Size
1 PREM14A projectrainbow-preliminary.htm PREM14A 2631903
2 EX-FILING FEES exhibit-filingfeetableopia.htm EX-FILING FEES 13960
3 image_0a.jpg GRAPHIC 110764
4 imagea.jpg GRAPHIC 6031
  Complete submission text file 0001385508-22-000145.txt   2808099
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-38193 | Film No.: 221478965
SIC: 2834 Pharmaceutical Preparations